Currently Funded Research Projects

Scientific Research:

Clinical Research:

Brigham and Women’s Hospital, Harvard

Massachusetts General Hospital

Johns Hopkins University

Mayo Clinic

Mayo Clinic

Stanford University – Steinman Lab

Stanford University – Han Lab

University of California, San Francisco – Verkman Lab

University of California, San Francisco – Zamvil Lab

University of California, Los Angeles

University of Colorado Denver

St. George’s University of London

University of Oxford

Mount Sinai School of Medicine

Completed Funded Research Projects

The Guthy-Jackson Charitable Foundation has funded research in order to find answers that will lead to the prevention, clinical treatment programs and a potential cure for NMO. Completed projects will greaten the understanding of the disease and what needs to be done moving forward towards a cure. The following are completed projects funded by The Guthy-Jackson Charitable Foundation.

Scientific Research:

	Molecular Studies of Neuromyelitis Optica in Mouse Models of Aquaporin-4 Autoimmunity: The Scripps Research Institute
	Development and Validation of Aquaporin Autoimmunity Models: Mayo Clinic
	Genetics of Neuromyelitis Optica and Molecular Basis of Susceptibility: Mayo Clinic
	Role of AQP4 Autoantibody in Neuromyelitis Optica: University of California, San Francisco – Verkman Lab
	Tcell Recognition of Aquaporin-4 in Neuromyelitis Optica: University of California, San Francisco – Zamvil Lab
	Proteomic Studies Leading to Development of Tolerizing Therapy in NMO: University of Stanford – Steinman Lab

Clinical Research:

• NMO Clinical Consortium

• Massachusetts General Hospital

• New York University

In the United States, our funding is focused on, but not limited to researchers who are affiliated with U.S. 501(c)(3) or other tax-exempt organizations. The Guthy-Jackson Charitable Foundation does not fund individuals who do not meet our funding criteria and eligibility.